PharmaDirections
- Company typePrivate
- Founded2003
- HeadquartersCary, United States
- Headcount101–250
- GTM typeB2B
- OfferingServices
PharmaDirections firmographics
Firmographics- Name
- PharmaDirections
- Legal name
- PharmaDirections, Inc.
- Website
- https://pharmadirections.com
- Company type
- Private
- Founded year
- 2003
- Operating status
- Acquired
- Headcount range
- 101–250 employees
- Ownership category
- akta.pro rank
PharmaDirections industry classification
Industry- Product category
- Pharmaceutical Drug Development Services
- NAICS
- Scientific Research and Development Services (5417), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Small-Molecule CMC Documentation & Regulatory Support (DMF/CMC) (HLAGAHAM)
Keywords
Where PharmaDirections is headquartered
LocationHeadquarters
- HQ city
- Cary
- HQ country
- United States
- HQ region
- North America
Offices5 records
Markets served
PharmaDirections business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales
Revenue model
- Drug Development Consulting Services: Professional services revenue from providing virtual drug development expertise to small biotech companies. Services span from discovery through commercialization, including regulatory affairs, CMC, preclinical, program management, and strategic consulting.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels3 records
PharmaDirections product offering
Product offeringCore offering
PharmaDirections is a virtual drug development company that provides consulting and execution services to small, start-up, and micro-biotech companies. The firm delivers expert support across the full drug development lifecycle, from discovery through regulatory approval, acting as an outsourced drug development partner for resource-constrained biotech sponsors.
Product overview
PharmaDirections operates as a virtual drug development services company offering an integrated platform of consulting and execution services rather than a standalone software product. The core offering is the Drug Development Services platform, supplemented by eight specialized service modules: Program & Project Management, Drug Discovery Services, CMC & Quality Management, Preclinical Expert Services, Predictive Pharmacokinetic Modeling, Regulatory Affairs Services, Intellectual Property Inventors, and Dosage Form Development. These services are delivered through a virtual team model — combining a core staff of senior experts and PMP-certified project managers with a network of 200+ associates and contract research organizations — enabling small biotech companies to access big-pharma-level expertise without maintaining a full-time in-house team. The services span the full drug development lifecycle from discovery through regulatory approval, with each module available individually or as part of a full integrated program.
Differentiator
Problem solved
Functional benefit
Products and services
- Drug Development Services
- Program & Project Management
- Drug Discovery Services
- CMC & Quality Management
- Preclinical Expert Services
- Predictive Pharmacokinetic Modeling
- Regulatory Affairs Services
Quantifiable outcome
- 45+ patents and patent applications generated for clients
- +3 more outcomes
Companies that use PharmaDirections
Customer profileNamed customers19 records
Segments3 records
Ideal customer profiles1 record
PharmaDirections technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability2 records
Feature2 records
PharmaDirections partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Danforth AdvisorsmajorDanforth Advisors announced the acquisition of PharmaDirections on August 25, 2025. This acquisition expands Danforth's integrated drug development services from discovery through commercialization. The move enhances Danforth's capabilities in supporting life science companies throughout drug development stages.
Scale indicators7 records
Recent moves5 records
Expansion highlights5 records
PharmaDirections competitors and assessment
Company assessmentDirect peers
- Certara: Drug development consulting and modeling & simulation firm with biosimulation tools. Direct overlap with PharmaDirections' pharmacokinetic modeling and regulatory strategy services for small biotech sponsors.
- Worldwide Clinical Trials: Mid-sized CRO focused on small and mid-sized biotech clients across the full drug development lifecycle. Directly comparable to PharmaDirections' full-spectrum, small-biotech-focused virtual development model.
- Rho: Mid-sized CRO with strong small and mid-biotech focus and full-spectrum drug development capabilities including regulatory, biostatistics, and clinical operations. Comparable scale and client profile to PharmaDirections.
- ProPharma Group: Pharmaceutical consulting and CRO providing regulatory, CMC, and drug development services to small and mid-sized pharma/biotech. Closely comparable service mix and client profile to PharmaDirections.
Broad incumbents
- Medpace: Large full-service CRO with significant small/mid biotech exposure and a cross-functional development offering. Competes with PharmaDirections for biotech-sponsored programs at larger scale.
- ICON plc: Global CRO offering drug development services across all phases, including dedicated biotech-focused units. Overlaps with PharmaDirections in biotech development support but at much larger scale.
- IQVIA: Largest CRO with end-to-end drug development capabilities and proprietary data assets. Competes for biotech contracts while also serving large pharma, making it a broad incumbent versus PharmaDirections' boutique focus.
- Charles River Laboratories: Established CRO/CDMO with discovery, preclinical, and clinical development capabilities. Comparable CMC, preclinical, and regulatory services to PharmaDirections but with manufacturing infrastructure.
Emerging players
- Frontage Laboratories: CRO/CDMO providing CMC, bioanalytical, and preclinical services to biotech and pharma. Overlaps with PharmaDirections' CMC, preclinical, and regulatory offerings.
- BioDuro: CRO/CDMO offering drug discovery, preclinical, and CMC services tailored to small and emerging biotech. Comparable virtual-leaning service model and biotech client focus.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
PharmaDirections social profiles
Digital presencePharmaDirections compliance and trust
Trust signalCompliance1 record
PharmaDirections financial estimates
Financial estimateRevenue estimate
Valuation estimate
PharmaDirections leadership team
Management profileNumber of profiles
PharmaDirections funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
PharmaDirections M&A and investment
M&A and investmentM&A
Investments1 record
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about PharmaDirections
What does PharmaDirections do?
PharmaDirections is a virtual drug development company that provides consulting and execution services to small, start-up, and micro-biotech companies. The firm delivers expert support across the full drug development lifecycle, from discovery through regulatory approval, acting as an outsourced drug development partner for resource-constrained biotech sponsors.
Is PharmaDirections a public or private company?
PharmaDirections is a private company. It is classified as corporate owned and is currently acquired.
When was PharmaDirections founded?
PharmaDirections was founded in 2003. It employs 101 to 250 people.
Where is PharmaDirections based?
PharmaDirections is headquartered in Cary, United States, in the North America region.
How does PharmaDirections make money?
One revenue line is on record: drug Development Consulting Services.
Who are PharmaDirections's main competitors?
Direct peers on record are Certara, Worldwide Clinical Trials, Rho and ProPharma Group. Broad incumbents are Medpace, ICON plc, IQVIA and Charles River Laboratories. Emerging players are Frontage Laboratories and BioDuro.
Does PharmaDirections have an API?
No public API is recorded for PharmaDirections.
What industry is PharmaDirections in?
PharmaDirections's product category is Pharmaceutical Drug Development Services. Its primary akta.pro industry code is HLAGAHAM, Small-Molecule CMC Documentation & Regulatory Support (DMF/CMC). Its NAICS code is 5417 and its SIC code is 8731.